Margarita K.
- Country
- Italy
- Department
- Diagnostic Imaging and Radiotherapy/Nuclear Medicine
Research Overview
- Phase I Evaluation of [177Lu]Lu-OncoFAP-23 and L19-IL2 in Metastatic FAP-Positive Solid Tumors
- Phase I Evaluation of Safety and Dosimetry of 68Ga-OncoACP3 in Prostate Cancer Patients with Suspected Metastasis or Recurrence
- Phase I Evaluation of Safety and Dosimetry of 68Ga-Labelled OncoFAP Derivatives in Patients with Solid Tumors: Breast, Colorectal, Oesophageal, and Pancreatic Adenocarcinoma
Data & Insights
Has run more than one trial at 3 of 8 partner sites.
Specializations
Oncological Diagnostics
Specializes in advanced diagnostic approaches for solid tumors, with particular emphasis on developing imaging techniques for FAP-positive tumors and prostate cancer evaluation.
- FAP-positive tumor detection
- Prostate cancer imaging
- Metastatic disease assessment
Employs innovative diagnostic methodologies using gallium-68 labeled compounds for cancer visualization.
Therapeutic Applications
Focuses on the development of targeted treatments for various cancers, including breast cancer, colorectal cancer, esophageal cancer, and pancreatic adenocarcinoma.
- Metastatic tumor treatment
- Combination therapy approaches
- Targeted radiotherapy applications
Investigates therapeutic applications using lutetium-177 based treatments for advanced cancers.
Specialized Cancer Care
Dedicated to advancing treatment options for patients with metastatic disease, particularly focusing on cases with elevated prostate-specific antigen (PSA) levels.
- Advanced cancer management
- Recurrence monitoring
- Personalized treatment strategies
Implements innovative approaches for treating both initial and recurrent cancer presentations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.